GENETETHER
GeneTether develops DNA Template-Nuclease-Tethering or TNTโข platform that allows to conjugate or tether donor DNA templates to CRISPR/Cas9 and other nucleases. The platform improves the efficiency of programming and modifying genes. GeneTether was co-founded by Har Grover, R. Geoffrey Sargent, William J. Garner, and Daren Graham in 2018 and is headquartered in San Lorenzo, California.
GENETETHER
Social Links:
Industry:
Biotechnology Genetics Health Care
Founded:
2018-01-01
Address:
San Lorenzo, California, United States
Country:
United States
Website Url:
http://www.genetether.com
Total Employee:
1+
Status:
Active
Contact:
510-207-2046
Email Addresses:
[email protected]
Total Funding:
912 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Content Delivery Network Wordpress Plugins Euro Microsoft Exchange Online
Similar Organizations
Celsius Therapeutics
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.genetether.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "GeneTether"
GeneTether Announces Organizational Changes Designed to โฆ
Oct 19, 2021 He joins GeneTether from Scientus Pharma Inc., where he served as the Director of Research and Development. Prior to Scientus, Dr. Sampson spent 10 years as a scientist in โฆSee details»
GeneTether Therapeutics Announces Name Change to Rize โฆ
Jan 9, 2025 Kelowna, British Columbia โ January 9, 2025 โ GeneTether Therapeutics Inc. (CSE: GTTX) today announced that it has changed its name to Rize Oncology Inc. (โRizeโ or โฆSee details»
GeneTether - Crunchbase Company Profile & Funding
GeneTether develops DNA Template-Nuclease-Tethering or TNTโข platform that allows to conjugate or tether donor DNA templates to CRISPR/Cas9 and other nucleases. The platform โฆSee details»
GeneTether Announces Organizational Changes Designed to โฆ
BERKELEY, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- GeneTether Inc. (โGeneTetherโ or the โCompanyโ), a Bay Area biotech company focused on developing technologies to increase the ...See details»
GeneTether - Org Chart, Teams, Culture & Jobs - The Org
View GeneTether's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
GeneTether - Leadership Team - The Org
The Leadership Team at GeneTether is responsible for setting the strategic direction, managing financial oversight, guiding scientific innovation, and overseeing research and development โฆSee details»
GeneTether Announces Organizational Changes Designed to โฆ
BERKELEY, Calif., Oct. 19, 2021 -- GeneTether Inc. , a Bay Area biotech company focused on developing technologies to increase the correction efficiency of targeted genome editing... โฆSee details»
GeneTether - Company Profile - Tracxn
GeneTether - Developer of Gene editing technologies to treat human diseases. Public Company. Raised a total funding of $396K over 1 round from 2 investors. Founded by Geoffrey Sargent โฆSee details»
GeneTether Therapeutics Inc (CSE: GTTX) - LinkedIn
GeneTether Therapeutics Inc (CSE: GTTX) | 226 followers on LinkedIn. Increasing the correction efficiency of targeted gene editing technologies | GeneTether Therapeutics (CSE: GTTX) is โฆSee details»
GeneTether - Overview, News & Similar companies | ZoomInfo.com
Mar 28, 2022 GeneTether Therapeutics is an innovative genetic medicines company focused on... Mar 28, 2022. www.newsfilecorp.com . Read more news. Frequently Asked Questions โฆSee details»
GeneTether, Inc. - VentureRadar
GeneTether is an early stage biotechnology company developing improved gene editing technologies using Crispr/Cas, TALEN, and Zinc-Finger nucleases for human therapeutic โฆSee details»
GeneTether - Scientific Research Team - The Org
The Scientific Research Team at GeneTether is responsible for advancing the company's proprietary genome editing platform through innovative research and development. They โฆSee details»
GeneTether - Contacts, Employees, Board Members, Advisors
GeneTether has 5 current employee profiles, including Chief Scientific Officer & Co-Founder R Geoffrey Sargent, PhD. GeneTether has 1 board member or advisor, Daren Graham . ContactsSee details»
GeneTether Therapeutics Inc. | CSE - Canadian Securities Exchange
GeneTether Therapeutics is an innovative genetic medicines company focused on creating best-in-class gene editing therapies based on our proprietary GeneTetherโข platform. Our platform โฆSee details»
GeneTether Therapeutics - Craft
Oct 28, 2024 GeneTether Therapeutics is a biopharmaceutical company that specializes in genetic medicines. It develops a platform for genome editing and allows cells to deliver โฆSee details»
GeneTether Therapeutics Inc. Announces Commencement of โฆ
Feb 8, 2023 Vancouver, B C - TheNewswire - February 8, 2023 - GeneTether Therapeutics Inc. (โ GeneTether โ or the โ Company โ) (CSE:GTTX), a preclinical-stage biotechnology company โฆSee details»
GeneTether Therapeutics Inc. completes C$4.5 million initial
On March 29, 2022, GeneTether Therapeutics Inc. (CSE: GTTX) ("GeneTether" or the "Company"), an innovative genetic medicines company, completed an initial public offering โฆSee details»
GeneTether Therapeutics Completes Initial Public Offering
Mar 29, 2022 Founded by EGB Ventures founder and managing partner, William J. Garner, M.D., and veteran gene editing researcher, R. Geoffrey Sargent, Ph.D., GeneTether is โฆSee details»
GeneTether Therapeutics Inc. - Odyssey Trust Company
GeneTether Therapeutics Inc. Annual General and Special Meeting. December 12, 2024. FORMs & DOCUMENTS. Management Information Circular. Form of Proxy. Financial Statement โฆSee details»
GeneTether | CipherBio
Explore GeneTether's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»